vs
EVERTEC, Inc.（EVTC）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
EVERTEC, Inc.的季度营收约是Orthofix Medical Inc.的1.1倍（$244.8M vs $219.9M），EVERTEC, Inc.净利率更高（15.1% vs -1.0%，领先16.1%），EVERTEC, Inc.同比增速更快（13.1% vs 2.0%），EVERTEC, Inc.自由现金流更多（$63.7M vs $16.8M），过去两年EVERTEC, Inc.的营收复合增速更高（9.2% vs 8.0%）
EVERTEC Inc.是总部位于波多黎各的领先全品类支付技术与交易处理服务商，主要面向拉丁美洲及加勒比地区的金融机构、零售商户和政府客户，提供商户收单、电子资金转账、数字支付解决方案及业务流程外包服务。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
EVTC vs OFIX — 直观对比
营收规模更大
EVTC
是对方的1.1倍
$219.9M
营收增速更快
EVTC
高出11.2%
2.0%
净利率更高
EVTC
高出16.1%
-1.0%
自由现金流更多
EVTC
多$46.9M
$16.8M
两年增速更快
EVTC
近两年复合增速
8.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $244.8M | $219.9M |
| 净利润 | $37.0M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 17.6% | 0.2% |
| 净利率 | 15.1% | -1.0% |
| 营收同比 | 13.1% | 2.0% |
| 净利润同比 | -8.9% | 92.4% |
| 每股收益（稀释后） | $0.57 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EVTCOFIX
| Q4 25 | $244.8M | $219.9M | ||
| Q3 25 | $228.6M | $205.6M | ||
| Q2 25 | $229.6M | $203.1M | ||
| Q1 25 | $228.8M | $193.6M | ||
| Q4 24 | $216.4M | $215.7M | ||
| Q3 24 | $211.8M | $196.6M | ||
| Q2 24 | $212.0M | $198.6M | ||
| Q1 24 | $205.3M | $188.6M |
净利润EVTCOFIX
| Q4 25 | $37.0M | $-2.2M | ||
| Q3 25 | $32.9M | $-22.8M | ||
| Q2 25 | $40.5M | $-14.1M | ||
| Q1 25 | $32.7M | $-53.1M | ||
| Q4 24 | $40.7M | $-29.1M | ||
| Q3 24 | $24.7M | $-27.4M | ||
| Q2 24 | $31.9M | $-33.4M | ||
| Q1 24 | $16.0M | $-36.0M |
毛利率EVTCOFIX
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% | ||
| Q1 24 | — | 67.5% |
营业利润率EVTCOFIX
| Q4 25 | 17.6% | 0.2% | ||
| Q3 25 | 16.5% | -8.3% | ||
| Q2 25 | 24.4% | -7.9% | ||
| Q1 25 | 21.6% | -25.2% | ||
| Q4 24 | 22.2% | -5.3% | ||
| Q3 24 | 19.6% | -9.6% | ||
| Q2 24 | 20.5% | -12.5% | ||
| Q1 24 | 16.0% | -15.6% |
净利率EVTCOFIX
| Q4 25 | 15.1% | -1.0% | ||
| Q3 25 | 14.4% | -11.1% | ||
| Q2 25 | 17.6% | -6.9% | ||
| Q1 25 | 14.3% | -27.4% | ||
| Q4 24 | 18.8% | -13.5% | ||
| Q3 24 | 11.7% | -13.9% | ||
| Q2 24 | 15.0% | -16.8% | ||
| Q1 24 | 7.8% | -19.1% |
每股收益（稀释后）EVTCOFIX
| Q4 25 | $0.57 | $-0.05 | ||
| Q3 25 | $0.51 | $-0.57 | ||
| Q2 25 | $0.62 | $-0.36 | ||
| Q1 25 | $0.50 | $-1.35 | ||
| Q4 24 | $0.62 | $-0.76 | ||
| Q3 24 | $0.38 | $-0.71 | ||
| Q2 24 | $0.49 | $-0.88 | ||
| Q1 24 | $0.24 | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $306.0M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $621.6M | $450.0M |
| 总资产 | $2.2B | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资EVTCOFIX
| Q4 25 | $306.0M | $82.0M | ||
| Q3 25 | $474.7M | $62.9M | ||
| Q2 25 | $290.6M | $65.6M | ||
| Q1 25 | $265.9M | $58.0M | ||
| Q4 24 | $273.6M | $83.2M | ||
| Q3 24 | $275.4M | $30.1M | ||
| Q2 24 | $257.7M | $26.4M | ||
| Q1 24 | $293.7M | $27.0M |
总债务EVTCOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益EVTCOFIX
| Q4 25 | $621.6M | $450.0M | ||
| Q3 25 | $663.8M | $442.5M | ||
| Q2 25 | $612.3M | $458.3M | ||
| Q1 25 | $542.1M | $458.3M | ||
| Q4 24 | $472.5M | $503.1M | ||
| Q3 24 | $502.6M | $525.9M | ||
| Q2 24 | $483.4M | $546.0M | ||
| Q1 24 | $507.3M | $570.3M |
总资产EVTCOFIX
| Q4 25 | $2.2B | $850.6M | ||
| Q3 25 | $2.1B | $832.6M | ||
| Q2 25 | $2.0B | $837.2M | ||
| Q1 25 | $1.9B | $823.1M | ||
| Q4 24 | $1.9B | $893.3M | ||
| Q3 24 | $1.9B | $867.9M | ||
| Q2 24 | $1.9B | $882.0M | ||
| Q1 24 | $2.0B | $906.0M |
负债/权益比EVTCOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $70.0M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $63.7M | $16.8M |
| 自由现金流率自由现金流/营收 | 26.0% | 7.6% |
| 资本支出强度资本支出/营收 | 2.6% | 4.9% |
| 现金转化率经营现金流/净利润 | 1.89× | — |
| 过去12个月自由现金流最近4个季度 | $203.7M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流EVTCOFIX
| Q4 25 | $70.0M | $27.7M | ||
| Q3 25 | $70.9M | $12.4M | ||
| Q2 25 | $48.5M | $11.6M | ||
| Q1 25 | $37.6M | $-18.4M | ||
| Q4 24 | $75.2M | $23.7M | ||
| Q3 24 | $53.6M | $11.7M | ||
| Q2 24 | $90.6M | $9.0M | ||
| Q1 24 | $40.7M | $-18.6M |
自由现金流EVTCOFIX
| Q4 25 | $63.7M | $16.8M | ||
| Q3 25 | $65.3M | $2.5M | ||
| Q2 25 | $43.5M | $4.5M | ||
| Q1 25 | $31.2M | $-25.1M | ||
| Q4 24 | $70.8M | $15.2M | ||
| Q3 24 | $49.7M | $6.3M | ||
| Q2 24 | $78.8M | $-360.0K | ||
| Q1 24 | $35.3M | $-29.1M |
自由现金流率EVTCOFIX
| Q4 25 | 26.0% | 7.6% | ||
| Q3 25 | 28.5% | 1.2% | ||
| Q2 25 | 18.9% | 2.2% | ||
| Q1 25 | 13.7% | -13.0% | ||
| Q4 24 | 32.7% | 7.0% | ||
| Q3 24 | 23.5% | 3.2% | ||
| Q2 24 | 37.2% | -0.2% | ||
| Q1 24 | 17.2% | -15.4% |
资本支出强度EVTCOFIX
| Q4 25 | 2.6% | 4.9% | ||
| Q3 25 | 2.5% | 4.8% | ||
| Q2 25 | 2.2% | 3.5% | ||
| Q1 25 | 2.8% | 3.5% | ||
| Q4 24 | 2.0% | 4.0% | ||
| Q3 24 | 1.8% | 2.7% | ||
| Q2 24 | 5.6% | 4.7% | ||
| Q1 24 | 2.6% | 5.6% |
现金转化率EVTCOFIX
| Q4 25 | 1.89× | — | ||
| Q3 25 | 2.16× | — | ||
| Q2 25 | 1.20× | — | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 1.85× | — | ||
| Q3 24 | 2.17× | — | ||
| Q2 24 | 2.84× | — | ||
| Q1 24 | 2.55× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EVTC
| Latin America Payments And Solutions | $101.5M | 41% |
| Business Solutions | $58.3M | 24% |
| Merchant Acquiring Net | $48.2M | 20% |
| Payment Services Puerto Rico Caribbean | $36.8M | 15% |
| Transferred At Point In Time | $4.0M | 2% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
